E. Coli Testing Market Future Opportunities 2025

Global E. Coli Testing Market: Snapshot

coli (Escherichia coli) is a fecal coliform bacteria commonly found in intestines of humans and animals. Most of the E. coli strains are harmless, however certain strains are known to cause harmful medical complications. These include neonatal meningitis, gastrointestinal infections, cholecystitis, bacteremia, urinary tract infection (UTI), cholangitis, and pneumonia and mainly spreads through contaminated water or food. As this organism is found in intestinal tract of humans, it is considered as an indicator of fecal contamination. Hence, food and water samples are regularly tested for E. coli to avoid foodborne infections. 

Sudden outbreak of drug resistant E. coli strains has raised serious health concerns. The epidemic has spread to various regions of the world including North America and parts of Europe. These factors have led governments and regulatory agencies to adopt preventive measures to avoid such epidemics. Hence Environment Protection Agencies (EPA) across the globe have laid strict guidelines for water testing. These guidelines are practiced by municipal water suppliers, bottled water suppliers, waste water treatment plants, and private well owners. 

Spurred by these factors, the global E. coli testing market is expected to reach US$2.36 bn by the end of 2025, from US$1.18 bn in 2016. If these figures hold true, the global E. coli testing market will exhibit a CAGR of 8.0% between 2017 and 2025.

 Request a Sample of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4822

Home and Drinking Water Segment to Continue Exhibiting Highest Demand 

In terms of environmental testing methods, the global E. coli testing market is bifurcated into environmental testing method and clinical testing methods. The environmental testing method segment is further classified into membrane filtration (MF), multiple tube fermentation (MTF), and enzyme substrate method. Of these, holding majority share, the enzyme substrate method emerged dominant in the market in 2016. As the method is relatively more cost-effective and does not require skilled professionals for conducting it, is likely to retain its top slot through the forecast period. 

Likewise, the clinical testing segment is classified into polymerase chain reaction (PCR), enzyme immunoassay (EIA) tests, and others. Of these, enzyme immunoassays testing will continue holding the largest share in the market through the forecast period. 

By end user, the market can be categorized as waste water treatment organizations, bottled water suppliers, home and drinking water suppliers, and others. Of these, holding over 49.7% of the market, the home and drinking water segment emerged dominant in 2016. While the segment is expected to remain at the lead through the coming years, the market will also witness rising demand from waste water treatment organizations. Furthermore, the increasing drinking water crisis and frequent outbreak of water borne diseases will put pressure on governments to ensure high standards of home and drinking water, thus sealing the dominance of the segment.

Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4822

North America to Remain Dominant Regional Market through Forecast Period 

Regionally, the global E. coli testing market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In 2016, North America held the dominant share of nearly 44.5% in the global E. coli testing market. North America has been one of the early adopters of the latest technologies. Besides this, the region also boasts a sophisticated healthcare infrastructure, which is aiding the growth of the E. coli testing market. 

Meanwhile, the Europe market is saturated and growing at slow rate while Asia Pacific is anticipated to witness the fastest CAGR during the forecast period with major contribution of countries such as India, Japan and China. New product launches, favorable regulations, ability of patients to pay for advanced technology products, and growing awareness are likely to drive the market in Asia Pacific during the forecast period. 

Some of the key players operating in the E. coli testing market are IDEXX Laboratories, Inc., Meridian Bioscience, Inc., Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., CPI International, Inc., Bio-Rad Laboratories, Inc., Pro-Lab Diagnostics, Inc., Alere Inc., BioMerieux Inc., and NanoLogix, Inc

Enquiry for discount on this report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=4822

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

This release was published on openPR.